| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of 1Physiology and 2Surgery, University of Manitoba, and 3lnstitute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, Winnipeg, Manitoba, Canada R2H 2A6
Submitted 8 March 2004 ; accepted in final form 23 July 2004
Phosphatidylinositol 3-kinase (PI3K) is required for smooth muscle cell (SMC) proliferation. This study reports that inhibitors of PI3K also prevent SMC migration and block neointimal hyperplasia in an organ culture model of restenosis. Inhibition of neointimal formation by LY-294002 was concentration and time dependent, with 10 µM yielding the maximal effect. Continuous exposure for at least the first 4–7 days of culture was essential for significant inhibition. To assess the role of matrix metalloproteinases (MMPs) in this process, we monitored MMP secretion by injured vessels in culture. Treatment with LY-294002 selectively reduced active MMP-2 in media samples according to zymography and Western blot analysis without concomitant changes in latent MMP-2. Parallel results with wortmannin indicate that MMP-2 activation is PI3K dependent. Previous research has shown a role for both furin and membrane-type 1 (MT1)-MMP (MMP-14) in the activation of MMP-2. The furin inhibitor decanoyl-Arg-Val-Lys-Arg-chloromethylketone did not prevent MMP-2 activation after balloon angioplasty. In contrast, balloon angioplasty induced a significant increase in the levels of MT1-MMP, which was suppressed by LY-294002. No change in MT1-MMP mRNA was observed with LY-294002, because equivalent amounts of this mRNA were present in both injured and noninjured vessels. These results implicate PI3K-dependent regulation of MT1-MMP protein synthesis and subsequent activation of latent MMP-2 as critical events in neointimal hyperplasia after vascular injury.
matrix metalloproteinase; LY-294002; wortmannin; furin; restenosis
This article has been cited by other articles:
|
|
 |
|
  A. Dwivedi, S. C. Slater, and S. J. George MMP-9 and -12 cause N-cadherin shedding and thereby {beta}-catenin signalling and vascular smooth muscle cell proliferation Cardiovasc Res, January 1, 2009; 81(1): 178 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Rupp, R. P. Visconti, A. Czirok, D. A. Cheresh, and C. D. Little Matrix Metalloproteinase 2-Integrin {alpha}v{beta}3 Binding Is Required for Mesenchymal Cell Invasive Activity but Not Epithelial Locomotion: A Computational Time-Lapse Study Mol. Biol. Cell, December 1, 2008; 19(12): 5529 - 5540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Qian, R. P. Hartman, B. F. King, and V. E. Torres Increased Occurrence of Pericardial Effusion in Patients with Autosomal Dominant Polycystic Kidney Disease Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1223 - 1227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ispanovic and T. L. Haas JNK and PI3K differentially regulate MMP-2 and MT1-MMP mRNA and protein in response to actin cytoskeleton reorganization in endothelial cells Am J Physiol Cell Physiol, October 1, 2006; 291(4): C579 - C588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Madani, S. De Girolamo, D. M. Munoz, R.-K. Li, and G. Sweeney Direct effects of leptin on size and extracellular matrix components of human pediatric ventricular myocytes Cardiovasc Res, February 15, 2006; 69(3): 716 - 725. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
